Clinical Trials
2 trialsNCT04126590 2023-09-01
Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors
Changchun Intellicrown Pharmaceutical Co. LTD
Phase 1 Unknown
NCT00725283 2018-08-07
Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)
GlaxoSmithKline
Phase 1 Completed